Earthlight® (Whole Food Mushroom Vitamin D2)

Agaricus bisporus
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

Earthlight® (PLT Health Solutions) is a whole food Vitamin D ingredient derived from UV-treated white button mushrooms (Agaricus bisporus) that provides plant-based Vitamin D2 in its natural food matrix — complete with the cofactors, fiber, beta-glucans, and phytonutrients present in whole mushrooms. Unlike isolated Vitamin D2 or D3 synthetics, Earthlight® delivers Vitamin D within its natural food context, making it ideal for plant-based, clean-label, and whole food positioning. Mushrooms are one of several non-animal sources of Vitamin D, alongside UV treated yeast, which also yields D2, and lichen, which yields D3. One limitation to know before buying: Earthlight® supplies Vitamin D2, and D2 is less effective than D3 at raising and holding up total 25-hydroxyvitamin D, so the outcome trials behind most Vitamin D health claims, which used D3, do not transfer to it directly.

Studied Dose 250-1000 IU Vitamin D2 equivalent per serving (25-100 mg Earthlight® mushroom powder).
Active Compound Vitamin D2 (ergocalciferol) in whole-mushroom matrix; UV-treated Agaricus bisporus (white button) powder with beta-glucans, fiber.

Benefits

Plant-based whole food Vitamin D for clean labels

Earthlight® provides Vitamin D in its natural food matrix — a whole food form rather than an isolated vitamin. It is not the only option of its kind, though: mushrooms are fungi rather than plants, several suppliers sell UV treated mushroom Vitamin D powder, and lichen derived vegan D3 and UV treated yeast D2 are also on the market. This meets growing consumer demand for plant-based, minimally processed, and clean-label nutrition without synthetic D3 (lanolin-derived) or isolated D2 ingredients. The mushroom food matrix also provides co-occurring immune-supportive beta-glucans, fiber, and antioxidants absent in isolated Vitamin D supplements.

Immune function support

Vitamin D from Earthlight® has a well established role in immune function — innate immunity (macrophage activation, antimicrobial peptide production), adaptive immunity (T-regulatory cell differentiation), and mucosal defense. These are textbook Vitamin D mechanisms from laboratory work and from D3 supplementation research, not findings from any study of Earthlight. The co-occurring mushroom beta-glucans provide additional immunomodulatory activity through Dectin-1 receptor activation, though no trial has tested Earthlight® for that synergy, and at a 25 to 100 mg serving the amount of mushroom beta-glucan is small next to the doses used in beta-glucan trials, which usually run from a few hundred milligrams to several grams. Worth knowing too: the respiratory infection meta-analysis cited below used Vitamin D3 in all 25 of its trials, the overall effect was modest, and the benefit was concentrated in people who were deficient to begin with rather than in those already replete.

Bone health and musculoskeletal support

Vitamin D is essential for calcium and phosphorus absorption required for bone mineralization, and it has a role in muscle function, although pooled trial data have not shown that supplementation prevents falls. Earthlight® has not been tested in any published trial for a bone or muscle outcome. The fracture meta-analysis behind Vitamin D's bone reputation used cholecalciferol (D3) at 700 to 800 IU a day in people aged 60 and over, and larger later trials in generally healthy adults found no fracture reduction, so treat this as a way to cover Vitamin D intake rather than as a proven fracture treatment. It is a whole food format acceptable for vegan, vegetarian, and clean-label product positioning.

Mechanism of action

1

Vitamin D2 nuclear receptor activation and calcium homeostasis

Vitamin D2 (ergocalciferol) from Earthlight® undergoes hepatic 25-hydroxylation to 25(OH)D2, then renal 1α-hydroxylation to 1,25(OH)2D2 (calcitriol equivalent), which binds the Vitamin D nuclear receptor (VDR) to regulate expression of over 1,000 genes governing calcium absorption (TRPV6, calbindin), immune function (cathelicidin, defensins), cell differentiation, and inflammatory modulation. D2 and D3 are not interchangeable. Pooled trial data show D3 raises total 25-hydroxyvitamin D more than D2 overall and holds it up for longer, an advantage driven mainly by large single doses, with less difference between the two when either is taken daily. A meta-analysis of six trials of UV exposed mushrooms found mushroom D2 raised 25(OH)D2 by about 20.6 nmol/L while at the same time lowering 25(OH)D3 by about 13.3 nmol/L, so pooled total 25-hydroxyvitamin D did not rise significantly, with the clearest gains in people whose starting level was low.

Clinical trials

1
UV-Treated Mushroom Vitamin D2 vs a D2 Supplement and Placebo — Bioequivalence Study

Urbain 2011, a 5-week single-blinded randomized placebo-controlled trial in Germany in 26 young adults with serum 25-hydroxyvitamin D at or below 50 nmol/L. Three arms: a soup made with UV-B irradiated button mushrooms supplying 28,000 IU of Vitamin D2 a week, the same 28,000 IU a week as a D2 supplement, or placebo. No Vitamin D3 arm, and no immune or bone outcome was measured. PMID 21540874.

Vitamin D-insufficient adults.

Serum 25-hydroxyvitamin D rose about 3.9 nmol/L a week in the mushroom group and about 4.7 nmol/L a week in the D2 supplement group, a similar rise in both, and the mushroom group was significantly higher than placebo by two weeks. Note the dose and the endpoint: 28,000 IU a week is roughly 4,000 IU a day, four to sixteen times what a 250 to 1,000 IU serving of this ingredient provides, and the only thing measured was a blood marker. Note: while D2 raises serum 25(OH)D2, the broader scientific consensus is that D3 (cholecalciferol) is more effective than D2 (ergocalciferol) at raising and maintaining total 25(OH)D levels (Tripkovic 2012, American Journal of Clinical Nutrition, PMID 22552031). Mushroom D2 is a popular vegan-friendly option but is not bioequivalent to D3 on a unit-for-unit basis.

Side effects and drug interactions

Common Potential side effects

Mushroom food ingredient — excellent safety profile
Mushroom allergy (rare) — discontinue if reaction
Vitamin D toxicity not a concern at food/supplement doses; signs of toxicity are unlikely below about 10,000 IU a day, though the tolerable upper intake level for adults is 4,000 IU a day from all sources combined, and this ingredient supplies 250 to 1,000 IU a serving

Important Drug interactions

Thiazide diuretics — Vitamin D may increase calcium; monitor
Corticosteroids — long-term use impairs Vitamin D metabolism; supplementation more important
No significant interactions at standard supplement doses

Frequently asked questions about Earthlight® (Whole Food Mushroom Vitamin D2)

What is Earthlight?

Earthlight® (PLT Health Solutions) is a whole food Vitamin D ingredient derived from UV-treated white button mushrooms (Agaricus bisporus) that provides plant-based Vitamin D2 in its natural food matrix — complete with the cofactors, fiber, beta-glucans, and phytonutrients present in whole mushrooms.

What is Earthlight used for?

Earthlight is researched primarily for Immune Support and Bone Health. Earthlight® provides Vitamin D in its natural food matrix — a whole food form rather than an isolated vitamin. It is not the only option of its kind, though: mushrooms are fungi rather than plants, several suppliers sell UV treated mushroom…

What is the recommended dosage of Earthlight?

The clinically studied dose is 250-1000 IU Vitamin D2 equivalent per serving (25-100 mg Earthlight® mushroom powder). Always follow the product label and check with a healthcare provider for personal advice.

Is Earthlight safe, and does it have side effects?

For most healthy adults, Earthlight is well tolerated at studied doses. Reported effects can include: Mushroom food ingredient — excellent safety profile Mushroom allergy (rare) — discontinue if reaction It may also interact with some medications. Earthlight is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Earthlight interact with any medications?

Possible interactions include: Thiazide diuretics — Vitamin D may increase calcium; monitor Corticosteroids — long-term use impairs Vitamin D metabolism; supplementation more important If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Earthlight?

NutraSmarts rates the evidence for Earthlight as Limited (2 out of 5). It is backed by 1 clinical trial and 7 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(7 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Urbain P, Singler F, Ihorst G, Biesalski HK, Bertz H Bioavailability of vitamin D2 from UV-B-irradiated button mushrooms in healthy adults deficient in serum 25-hydroxyvitamin D: a randomized controlled trial. Eur J Clin Nutr. 2011;65(8):965-71. doi: 10.1038/ejcn.2011.53.PubMedUsed to support: RCT (n=26, 5 weeks) demonstrating that UV-B-irradiated button mushrooms providing 28,000 IU/week of vitamin D2 raised serum 25-hydroxyvitamin D as effectively as a vitamin D2 supplement; the trial measured serum 25-hydroxyvitamin D only, with no vitamin D3 arm, no immune outcome and no bone outcome, and at 28,000 IU a week it used roughly 4,000 IU a day, four to sixteen times this product's 250 to 1,000 IU serving.
  2. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Griffiths CJ, Janssens W, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S Jr, Stelmach I, Kumar GT, Urashima M, Camargo CA Jr Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. doi: 10.1136/bmj.i6583.PubMedUsed to support: Landmark meta-analysis of 25 RCTs (n=10,933) showing vitamin D supplementation significantly reduced acute respiratory tract infection risk (aOR 0.88); but note the form mismatch: the paper states that all 25 included trials administered oral vitamin D3, not the D2 this ingredient supplies. The effect was also modest and uneven, with benefit among daily or weekly dosing concentrated in people deficient at baseline (adjusted odds ratio 0.30 below 25 nmol/L versus 0.75 above it) and no benefit from one or more bolus doses.
  3. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005;293(18):2257-64. doi: 10.1001/jama.293.18.2257.PubMedUsed to support: Meta-analysis of 12 RCTs showing 700-800 IU/day vitamin D supplementation reduced hip fracture risk by 26% and nonvertebral fracture risk by 23% in older adults; but two caveats apply. The paper states that all included trials used cholecalciferol, D3, not the D2 this ingredient supplies, and the population was ambulatory or institutionalized people aged 60 and over, not general adults. The 2005 finding has also not held up in later work: an 81-trial pooled analysis in 2018 and the 25,871-person VITAL trial in 2022 found no fracture reduction in generally healthy adults.
  4. Cashman KD, Kiely M, Seamans KM, et al. Effect of Ultraviolet Light-Exposed Mushrooms on Vitamin D Status: Liquid Chromatography-Tandem Mass Spectrometry Reanalysis of Biobanked Sera from a Randomized Controlled Trial and a Systematic Review plus Meta-Analysis. J Nutr. 2016;146(3):565-75..PubMedUsed to support: The most directly on-material reference available for this ingredient. Pooling six randomized trials of UV exposed mushrooms, 25(OH)D2 rose by 20.6 nmol/L (95% CI 8.0 to 33.3) while 25(OH)D3 fell by 13.3 nmol/L (95% CI -15.8 to -10.7), so the change in total 25-hydroxyvitamin D was not significant overall (P=0.12), with a significant 15.2 nmol/L rise only in the European trials where baseline status was lower. Supports the corrected mechanism text and the caveat that someone already replete may see little change in total Vitamin D status.
  5. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-64..PubMedUsed to support: Vitamin D3 raised serum 25-hydroxyvitamin D significantly more than D2 (P=0.001), an effect driven by large single doses (P=0.0002) with no significant difference for daily dosing (P=0.10). This is the correct locator for the trial card's truncated AJCN parenthesis and the source for the D2 versus D3 caveat, including the honest detail that the gap narrows when either form is taken daily.
  6. Bolland MJ, Grey A, Avenell A Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6(11):847-858..PubMedUsed to support: Eighty-one randomized trials in 53,537 participants: vitamin D supplementation did not prevent fractures or falls and produced no clinically relevant difference in bone mineral density at any site, at high or low dose. Supports the corrected falls wording in the bone benefit and the caveat added to the 2005 fracture meta-analysis.
  7. LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. N Engl J Med. 2022;387(4):299-309..PubMedUsed to support: The VITAL fracture ancillary study, 25,871 participants given 2000 IU a day of vitamin D3 for a median of 5.3 years: no significant reduction in total fracture (hazard ratio 0.98), nonvertebral fracture or hip fracture in generally healthy adults not selected for deficiency, low bone mass or osteoporosis. Needed alongside the 2005 fracture meta-analysis so the bone claim does not rest on a single positive result from twenty years ago.